Inhibition of the catabolic enzyme UGCG inhibited proliferation and induced apoptosis of breast cancer cells and enhanced the inhibitory effects of chemotherapeutic drugs in vivo and in vitro [40]. This evidence concerns the gene UGCG and breast cancer.